- Home
- SHLT vs ANEB Comparison
SHLT vs ANEB Comparison
Compare SHLT & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHLT
- ANEB
- Stock Information
- Founded
- SHLT 1987
- ANEB 2020
- Country
- SHLT Israel
- ANEB United States
- Employees
- SHLT N/A
- ANEB N/A
- Industry
- SHLT Business Services
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- SHLT Consumer Discretionary
- ANEB Health Care
- Exchange
- SHLT Nasdaq
- ANEB Nasdaq
- Market Cap
- SHLT 39.3M
- ANEB 36.7M
- IPO Year
- SHLT N/A
- ANEB 2021
- Fundamental
- Price
- SHLT $2.02
- ANEB $1.15
- Analyst Decision
- SHLT
- ANEB Buy
- Analyst Count
- SHLT 0
- ANEB 1
- Target Price
- SHLT N/A
- ANEB $8.00
- AVG Volume (30 Days)
- SHLT 9.5K
- ANEB 53.1K
- Earning Date
- SHLT 04-24-2025
- ANEB 05-14-2025
- Dividend Yield
- SHLT N/A
- ANEB N/A
- EPS Growth
- SHLT N/A
- ANEB N/A
- EPS
- SHLT N/A
- ANEB N/A
- Revenue
- SHLT $55,939,000.00
- ANEB N/A
- Revenue This Year
- SHLT N/A
- ANEB N/A
- Revenue Next Year
- SHLT N/A
- ANEB N/A
- P/E Ratio
- SHLT N/A
- ANEB N/A
- Revenue Growth
- SHLT N/A
- ANEB N/A
- 52 Week Low
- SHLT $1.85
- ANEB $0.80
- 52 Week High
- SHLT $6.73
- ANEB $3.30
- Technical
- Relative Strength Index (RSI)
- SHLT 38.63
- ANEB 38.90
- Support Level
- SHLT $1.85
- ANEB $1.14
- Resistance Level
- SHLT $2.57
- ANEB $1.40
- Average True Range (ATR)
- SHLT 0.27
- ANEB 0.26
- MACD
- SHLT -0.04
- ANEB -0.05
- Stochastic Oscillator
- SHLT 22.67
- ANEB 0.95
About SHLT SHL Telemedicine Ltd
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.